Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of IV Rt-PA Treatment in Chinese AIS Patients Aged Above 80 Years: a Real-world Study

NCT05401149 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT05401149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05401149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of IV Rt-PA Treatment in Chinese AIS Patients Aged Above 80 Years: a Real-world Study
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
July 18, 2022
Completion date
December 14, 2022
Enrollment
3,058 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke